Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2026-04-04 @ 12:22 PM
Study NCT ID:
NCT00298467
Status:
WITHDRAWN
Last Update Posted:
2010-04-26
First Post:
2006-03-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma
Sponsor:
Bristol-Myers Squibb
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lymphoma, Large-Cell | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | ALCL | View |
| None | csALCL | View |
| None | pcALCL | View |
| None | Lymphoma | View |
| None | Non-Hodgkin's Lymphoma | View |
| None | Anaplastic Large Cell Lymphoma | View |
| None | classic systemci Anaplastic Large Cell Lymphoma (csALCL) | View |
| None | primary cutaneous Anaplastic Large Cell Lymphoma (pcALCL) | View |